Results 91 to 100 of about 1,619,240 (186)

Prevalence of Diabetic Retinopathy and Use of Common Oral Hypoglycemic Agents Increase the Risk of Diabetic Nephropathy-A Cross-Sectional Study in Patients with Type 2 Diabetes. [PDF]

Int J Environ Res Public Health, 2023
Luo WM, Su JY, Xu T, Fang ZZ.
europepmc   +1 more source

Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study (Diabetes Metab J 2021;45:675-83). [PDF]

Diabetes Metab J, 2022
Oh TJ.
europepmc   +2 more sources

Effects of Hypoglycemic Agents on Pulmonary Diseases: A Comprehensive Narrative Review. [PDF]

J Inflamm Res
Yang Y, Wang K, Chen S.
europepmc   +1 more source

Adherence to Hypoglycemic Agents in Type 2 Diabetes Mellitus: A Cross-Sectional Study. [PDF]

Cureus, 2022
Khayyat YA, Alshamrani RM, Bintalib DM, Alzahrani NA, Alqutub S.   +4 more
europepmc   +1 more source

Network and Pairwise Meta-Analysis of the Association Between Novel Hypoglycemic Agents and Atrial Fibrillation Risk in Patients With Type 2 Diabetes Mellitus. [PDF]

Diabetes Metab Res Rev
Ye X, Wu Q, Hou L, Hou X, Yang Y, Yang C, Huang M, Wang S.   +7 more
europepmc   +1 more source

Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition. [PDF]

Acta Pharm Sin B, 2023
Xie Y, Zhou Q, He Q, Wang X, Wang J.
europepmc   +1 more source

Effects of Hypoglycemic Agents on The Musculoskeletal System: A Comprehensive Review. [PDF]

Drug Des Devel Ther
Zhao J, Lv SS, Lu Q, Cong XX, Zhang XF.
europepmc   +1 more source

Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis. [PDF]

Diab Vasc Dis Res, 2022
Oh S, Purja S, Shin H, Kim M, Kim E.
europepmc   +1 more source

Caffeoylquinic Acids From Lonicera japonica Thunb. as Hypoglycemic Agents: Network Pharmacology and Pharmacological Validation. [PDF]

J Diabetes Res
Ye Y, Xu D, Zhang S, Yu H, Liu Y, Yang J, Sun L.   +6 more
europepmc   +1 more source

Comparison of efficacy and safety of three novel hypoglycemic agents in patients with severe diabetic kidney disease: A systematic review and network meta-analysis of randomized controlled trials. [PDF]

Front Endocrinol (Lausanne), 2022
Li Y, Hu Y, Huyan X, Chen K, Li B, Gu W, Mu Y.   +6 more
europepmc   +1 more source